Ageing and multiple sclerosis

JS Graves, KM Krysko, LH Hua, M Absinta… - The Lancet …, 2023 - thelancet.com
The factor that is most relevant and strongly associated with the clinical course of multiple
sclerosis is chronological age. Very young patients exclusively have relapsing remitting …

Therapeutic advances in multiple sclerosis

JH Yang, T Rempe, N Whitmire, A Dunn-Pirio… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …

Molecular mechanisms of immunosenescene and inflammaging: relevance to the immunopathogenesis and treatment of multiple sclerosis

O Perdaens, V Van Pesch - Frontiers in neurology, 2022 - frontiersin.org
Aging is characterized, amongst other features, by a complex process of cellular
senescence involving both innate and adaptive immunity, called immunosenescence and …

Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration

S Thakolwiboon, EA Mills, J Yang, J Doty, MI Belkin… - Frontiers in …, 2023 - frontiersin.org
Aging is associated with a progressive decline of innate and adaptive immune responses,
called immunosenescence. This phenomenon links to different multiple sclerosis (MS) …

Genetic, environmental and lifestyle determinants of accelerated telomere attrition as contributors to risk and severity of multiple sclerosis

M Hecker, J Bühring, B Fitzner, PS Rommer, UK Zettl - Biomolecules, 2021 - mdpi.com
Telomeres are protective structures at the ends of linear chromosomes. Shortened telomere
lengths (TL) are an indicator of premature biological aging and have been associated with a …

A causal relationship between leukocyte telomere length and multiple sclerosis: a Mendelian randomization study

Q Liao, J He, FF Tian, FF Bi, K Huang - Frontiers in immunology, 2022 - frontiersin.org
Objectives Multiple sclerosis (MS) is a chronic inflammatory autoimmune and degenerative
disorder of the central nervous system. Telomeres are protective structures located at the …

[HTML][HTML] Systematic review of studies on telomere length in patients with multiple sclerosis

J Bühring, M Hecker, B Fitzner, UK Zettl - Aging and disease, 2021 - ncbi.nlm.nih.gov
Telomeres are protective cap structures at the end of chromosomes that are essential for
maintaining genomic stability. Accelerated telomere shortening is related to premature …

Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis

BA 't Hart, A Luchicchi, GJ Schenk… - Annals of Clinical …, 2021 - Wiley Online Library
The neuroinflammatory disease multiple sclerosis is driven by autoimmune pathology in the
central nervous system. However, the trigger of the autoimmune pathogenic process is …

Immunosenescence and multiple sclerosis

M Adamczyk-Sowa, M Nowak-Kiczmer… - Neurologia i …, 2022 - journals.viamedica.pl
Abstract Changes in the immune system associated with ageing are known as
immunosenescence. This is characterised by a decline in immune response, chronic …

Immunosenescence in neurological diseases—is there enough evidence?

PS Rommer, G Bsteh, T Zrzavy, R Hoeftberger… - Biomedicines, 2022 - mdpi.com
The aging of the immune system has recently attracted a lot of attention. Immune
senescence describes changes that the immune system undergoes over time. The …